BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 25309423)

  • 1. Neuroprotective effects of resveratrol in Alzheimer disease pathology.
    Rege SD; Geetha T; Griffin GD; Broderick TL; Babu JR
    Front Aging Neurosci; 2014; 6():218. PubMed ID: 25309423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol and Alzheimer's Disease: Mechanistic Insights.
    Ahmed T; Javed S; Javed S; Tariq A; Šamec D; Tejada S; Nabavi SF; Braidy N; Nabavi SM
    Mol Neurobiol; 2017 May; 54(4):2622-2635. PubMed ID: 26993301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential.
    Sousa JCE; Santana ACF; MagalhÃes GJP
    Arq Neuropsiquiatr; 2020 Jun; 78(8):501-511. PubMed ID: 32520230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of resveratrol in Alzheimer's disease.
    Rao YL; Ganaraja B; Joy T; Pai MM; Ullal SD; Murlimanju BV
    Front Biosci (Elite Ed); 2020 Jan; 12(1):139-149. PubMed ID: 31585875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol, a neuroprotective supplement for Alzheimer's disease.
    Li F; Gong Q; Dong H; Shi J
    Curr Pharm Des; 2012; 18(1):27-33. PubMed ID: 22211686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease.
    Rahman MH; Akter R; Bhattacharya T; Abdel-Daim MM; Alkahtani S; Arafah MW; Al-Johani NS; Alhoshani NM; Alkeraishan N; Alhenaky A; Abd-Elkader OH; El-Seedi HR; Kaushik D; Mittal V
    Front Pharmacol; 2020; 11():619024. PubMed ID: 33456444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcuminoids and resveratrol as anti-Alzheimer agents.
    Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):515-25. PubMed ID: 23276553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Progress on Alzheimer's Disease and Resveratrol.
    Yan Y; Yang H; Xie Y; Ding Y; Kong D; Yu H
    Neurochem Res; 2020 May; 45(5):989-1006. PubMed ID: 32162143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol: Protective Agent Against Alzheimer's Disease.
    Subhan I; Siddique YH
    Cent Nerv Syst Agents Med Chem; 2024 Mar; ():. PubMed ID: 38468523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
    Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
    Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic protective effects of phytochemicals in Alzheimer's disease.
    Davinelli S; Sapere N; Zella D; Bracale R; Intrieri M; Scapagnini G
    Oxid Med Cell Longev; 2012; 2012():386527. PubMed ID: 22690271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced inflammation and oxidative stress.
    Chiang MC; Nicol CJ; Cheng YC
    Neurochem Int; 2018 May; 115():1-10. PubMed ID: 28989083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical interaction of resveratrol with sirtuin pathway: Significance in Alzheimer's disease.
    Mohan S; Gobinath T; Salomy A; Nisha M; Kandasamy M; Essa MM; Jayachandran KS; Anusuyadevi M
    Front Biosci (Landmark Ed); 2018 Mar; 23(7):1380-1390. PubMed ID: 29293440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1.
    Gomes BAQ; Silva JPB; Romeiro CFR; Dos Santos SM; Rodrigues CA; Gonçalves PR; Sakai JT; Mendes PFS; Varela ELP; Monteiro MC
    Oxid Med Cell Longev; 2018; 2018():8152373. PubMed ID: 30510627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease.
    Braidy N; Jugder BE; Poljak A; Jayasena T; Mansour H; Nabavi SM; Sachdev P; Grant R
    Curr Top Med Chem; 2016; 16(17):1951-60. PubMed ID: 26845555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol Derivatives as Potential Treatments for Alzheimer's and Parkinson's Disease.
    Arbo BD; André-Miral C; Nasre-Nasser RG; Schimith LE; Santos MG; Costa-Silva D; Muccillo-Baisch AL; Hort MA
    Front Aging Neurosci; 2020; 12():103. PubMed ID: 32362821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.